Literature DB >> 10526432

Breast cancer patients' out-of-pocket expenses.

K A Moore1.   

Abstract

Patients with cancer soon discover that there is much more to the cost of treatment than hospital and physician bills. Out-of-packet expenses for transportation, food supplements, over-the-counter medications, distractions, telephone bills, insurance premiums--at a time when employment may be out of the question--can be a significant drain on family finances. Women with regional breast cancer reported their estimates of out-of-pocket expenses incurred during 1 month of outpatient chemotherapy. All women in the study were covered by some form of insurance. Mean monthly out-of-pocket costs were $360 (SD = $346), and ranged from $36 to $1224. Additional costs for wigs, special events, gifts, and alternative treatment incurred since diagnosis, ranged from $20 to $3700. These costs excluded expenses for health providers. Very low and very high expenditures may indicate risks concealed from providers that may have subsequent impact on long-term capacity to sustain treatment. Nurses can help families anticipate expenses and prioritize referrals to community agencies.

Entities:  

Mesh:

Year:  1999        PMID: 10526432     DOI: 10.1097/00002820-199910000-00007

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  29 in total

1.  'The bills that were coming in…': out of pocket costs during relocation for specialist treatment for haematological malignancies.

Authors:  Pam McGrath
Journal:  Support Care Cancer       Date:  2016-02-04       Impact factor: 3.603

2.  Gender, age and surgery as a treatment modality leads to higher distress in patients with cancer.

Authors:  Bejoy C Thomas; V NandaMohan; Madhvan K Nair; Manoj Pandey
Journal:  Support Care Cancer       Date:  2010-02-23       Impact factor: 3.603

3.  Out of pocket cost comparison between Caucasian and minority breast cancer survivors in the Breast Cancer Education Intervention (BCEI).

Authors:  Maria Pisu; Andres Azuero; Karen Meneses; Jeffrey Burkhardt; Patrick McNees
Journal:  Breast Cancer Res Treat       Date:  2010-10-26       Impact factor: 4.872

4.  Accurate Measurement of Financial Toxicity Is a Prerequisite to Finding a Remedy.

Authors:  Adam Martin; Peter S Hall
Journal:  Breast Care (Basel)       Date:  2017-04-26       Impact factor: 2.860

5.  Acute skin toxicity-related, out-of-pocket expenses in patients with breast cancer treated with external beam radiotherapy: a descriptive, exploratory study.

Authors:  Julie B Schnur; Joshua Graff Zivin; David M K Mattson; Sheryl Green; Lina H Jandorf; A Gabriella Wernicke; Guy H Montgomery
Journal:  Support Care Cancer       Date:  2012-03-18       Impact factor: 3.603

6.  The impact of outpatient systemic anti-cancer treatment on patient costs and work practices.

Authors:  D C Collins; M Coghlan; B T Hennessy; L Grogan; P G Morris; O S Breathnach
Journal:  Ir J Med Sci       Date:  2016-08-06       Impact factor: 1.568

7.  Pre-diagnosis employment status and financial circumstances predict cancer-related financial stress and strain among breast and prostate cancer survivors.

Authors:  Linda Sharp; Aileen Timmons
Journal:  Support Care Cancer       Date:  2015-07-05       Impact factor: 3.603

8.  Validity of information obtained from a method for estimating cancer costs from the perspective of patients and caregivers.

Authors:  Sophie Lauzier; Elizabeth Maunsell; Mélanie Drolet; Douglas Coyle; Nicole Hébert-Croteau
Journal:  Qual Life Res       Date:  2010-01-22       Impact factor: 4.147

9.  The multidimensional nature of the financial and economic burden of a cancer diagnosis on patients and their families: qualitative findings from a country with a mixed public-private healthcare system.

Authors:  Aileen Timmons; Rachael Gooberman-Hill; Linda Sharp
Journal:  Support Care Cancer       Date:  2012-07-20       Impact factor: 3.603

10.  Perceptions of health care providers concerning patient and health care provider strategies to limit out-of-pocket costs for cancer care.

Authors:  M Mathews; S Buehler; R West
Journal:  Curr Oncol       Date:  2009-08       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.